01/29/2015 – Salix Pharmaceuticals Ltd.

Issued: 01/29/2015

Salix Pharmaceuticals Ltd, SLXP:

1. Our previous (Tues. January 27) report on Salix Pharmaceuticals indicated new long entry upon any hourly or especially a daily close above $127.50 for further advance and test/attempt at 134.50/$136.50 (or higher) into next week (week of Feb. 2 +/-1 week).

2. In spite of the recent (forecast) broad market decline Salix Pharmaceuticals advanced powerfully today (Thurs., Jan. 29) and completed the $136.50 upside profit target (today’s session high, $137.61, so far).

3. Partial long position exits were taken at/near the $134.50 initial target, further exits were taken at/near $136.50. Will message any remaining long position exits in a subsequent update.

4. Our protective sell stop has been placed at $131.50. This stop will be moved higher as the market continues to confirm.

David Williams

Issued: 02/04/2015

Salix Pharmaceuticals Ltd, SLXP:

1. Our previous (Tues. January 27) report on Salix Pharmaceuticals indicated new long entry upon any hourly or especially a daily close above $127.50 for further advance and test/attempt at 134.50/$136.50 (or higher) into next week (week of Feb. 2 +/-1 week).

2. On Thurs., Jan. 29 Salix Pharmaceuticals completed the $136.50 upside profit target.

3. Final long position exit should now be taken at current prices (current price, $139.78). This completes the trade. Will message any further entry or indication in Salix Pharmaceuticals.

David Williams

Issued: 01/26/2015

Salix pharmaceuticals Ltd, SLXP:

1. During recent Williams edge live stock meetings it was noted that Salix pharmaceuticals was in position for further advance and test/attempt at $135/$37 into Friday (Jan. 23/Mon. Jan. 26).

2. While the price portion of the forecast was correct, the week of Jan. 26 (+1 week) is the correct timeframe that the price targets are expected. Will message any new entry based upon this as the market confirms during this week.

David Williams

Issued: 01/27/2015

Salix Pharmaceuticals Ltd, SLXP:

1. Any hourly or especially a daily close above $127.50 will place Salix Pharmaceuticals Ltd in a ‘Buy’ position for further advance and test/attempt at 134.50/$136.50 (or higher) into next week (week of Feb. 2 +/-1 week).

2. Initial long position exit should be taken at/near $131 and further exit taken at/near $134. Any remaining long position should be held for higher prices to be messaged in a subsequent update.

3. A protective sell stop will be messaged upon confirmation as noted above.

David Williams